다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

NVO

Novo Nordisk (NVO)

Novo Nordisk

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:NVO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/24	21:00	PR Newswire (US)	Novo Nordisk expands Wegovy® $499-per-month offering to additional cash-paying patients via the Wegovy® savings offer	NYSE:NVO	Novo Nordisk
2025/03/24	18:45	PR Newswire (US)	The Gross Law Firm Notifies Shareholders of Novo Nordisk A/S(NVO) of a Class Action Lawsuit and an Upcoming Deadline	NYSE:NVO	Novo Nordisk
2025/03/20	18:04	PR Newswire (US)	Shareholders that lost money on Novo Nordisk A/S(NVO) Urged to Join Class Action - Contact The Gross Law Firm to Learn More	NYSE:NVO	Novo Nordisk
2025/03/17	18:45	PR Newswire (US)	Class Action Filed Against Novo Nordisk A/S (NVO) - March 25, 2025 Deadline to Join - Contact The Gross Law Firm	NYSE:NVO	Novo Nordisk
2025/03/13	18:45	PR Newswire (US)	The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Novo Nordisk A/S Lawsuit - NVO	NYSE:NVO	Novo Nordisk
2025/03/10	20:58	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVO	Novo Nordisk
2025/03/10	18:45	PR Newswire (US)	NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline	NYSE:NVO	Novo Nordisk
2025/03/06	19:45	PR Newswire (US)	The Gross Law Firm Notifies Shareholders of Novo Nordisk A/S(NVO) of a Class Action Lawsuit and an Upcoming Deadline	NYSE:NVO	Novo Nordisk
2025/03/05	22:00	PR Newswire (US)	Novo Nordisk introduces NovoCare® Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients	NYSE:NVO	Novo Nordisk
2025/03/03	19:45	PR Newswire (US)	Shareholders that lost money on Novo Nordisk A/S(NVO) should contact The Gross Law Firm about pending Class Action - NVO	NYSE:NVO	Novo Nordisk
2025/02/28	00:58	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVO	Novo Nordisk
2025/02/27	19:45	PR Newswire (US)	Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - NVO	NYSE:NVO	Novo Nordisk
2025/02/24	19:45	PR Newswire (US)	Class Action Filed Against Novo Nordisk A/S (NVO) - March 25, 2025 Deadline to Join - Contact The Gross Law Firm	NYSE:NVO	Novo Nordisk
2025/02/20	19:45	PR Newswire (US)	Novo Nordisk A/S Sued for Securities Law Violations - Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - NVO	NYSE:NVO	Novo Nordisk
2025/02/13	19:45	PR Newswire (US)	Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NVO	NYSE:NVO	Novo Nordisk
2025/02/10	19:45	PR Newswire (US)	The Gross Law Firm Reminds Novo Nordisk A/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - NVO	NYSE:NVO	Novo Nordisk
2025/02/06	21:36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVO	Novo Nordisk
2025/02/06	19:45	PR Newswire (US)	The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline - NVO	NYSE:NVO	Novo Nordisk
2025/02/03	19:45	PR Newswire (US)	March 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVO	NYSE:NVO	Novo Nordisk
2025/01/30	19:45	PR Newswire (US)	NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline	NYSE:NVO	Novo Nordisk
2025/01/27	23:05	IH Market News	Tech Stocks May Lead Early Sell-Off On Wall Street	NYSE:NVO	Novo Nordisk
2025/01/25	06:44	IH Market News	U.S. Stocks Move To The Downside But Post Strong Weekly Gains	NYSE:NVO	Novo Nordisk
2024/12/03	20:00	GlobeNewswire Inc.	Defiance Launches NVOX, the First 2X Leveraged Single-Stock ETF on Novo Nordisk	NYSE:NVO	Novo Nordisk
2024/11/26	01:17	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVO	Novo Nordisk
2024/11/19	23:24	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVO	Novo Nordisk
2024/11/19	01:19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVO	Novo Nordisk
2024/11/09	07:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVO	Novo Nordisk
2024/11/09	06:53	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVO	Novo Nordisk
2024/11/09	06:50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVO	Novo Nordisk
2024/11/06	20:36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVO	Novo Nordisk

검색 관련기사 보기:NYSE:NVO

1 2 3 4 5 6 7 8 9 10 다음 >>

Ryohin Keikaku (PK)

Rse Archive (GM)

Aurora Energy Metals (PK)

Petrus Resources

BNP Paribas Issuance

DJ Greece Total Stock Ma...

Northern Graphite

Rheinmetall Berlin (PK)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관